AU Patent

AU2015250574B2 — Preparation containing tetracyclic compound at high dose

Assigned to Chugai Pharmaceutical Co Ltd · Expires 2020-07-16 · 6y expired

What this patent protects

Granules of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl- piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof are produced, and the granules are allowed to coexist with a disintegrating agent to prepare a composition or a preparation. In this man…

USPTO Abstract

Granules of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl- piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof are produced, and the granules are allowed to coexist with a disintegrating agent to prepare a composition or a preparation. In this manner, a composition or a preparation each containing the above-mentioned compound at a high dose can exhibit good elution properties.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015250574B2
Jurisdiction
AU
Classification
—
Expires
2020-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Chugai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.